The appellant appealed a decision upholding a finding of incapacity to consent to treatment with antipsychotic medication.
The Court of Appeal found that the Consent and Capacity Board's decision was unreasonable because there was no evidence that the proposed treatment would benefit the appellant, nor any evidence of the consequences of refusing treatment.
The appeal was allowed and the finding of incapacity was set aside.
